Yekaterina Chudnovsky - 12 Aug 2024 Form 4 Insider Report for Elicio Therapeutics, Inc. (ELTX)

Role
Director, 10%+ Owner
Signature
/s/ Yekaterina Chudnovsky
Issuer symbol
ELTX
Transactions as of
12 Aug 2024
Net transactions value
+$20,000,001
Form type
4
Filing time
14 Aug 2024, 16:41:38 UTC
Previous filing
02 Jul 2024
Next filing
25 Nov 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELTX Convertible Note (convertible into Common Stock) Purchase $20,000,001 +3,442,341 $5.81 3,442,341 12 Aug 2024 Common Stock 3,442,341 $5.81 Held by GKCC, LLC F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On August 12, 2024, GKCC, LLC (the "Purchaser") purchased from the Issuer a convertible note with an aggregate principal amount of $20,000,000 (the "Convertible Note"). The Convertible Note is convertible into shares of common stock of the Issuer at a conversion price of $5.81 per share, subject to adjustment in certain circumstances. Therefore, the Convertible Note is initially convertible into approximately 3,442,341 shares of common stock of the Issuer.
F2 The Convertible Note will mature on February 15, 2026, unless earlier converted in accordance with the terms of the Convertible Note. Interest on the Convertible Note is payable in cash and will accrue and be payable quarterly on the principal amount equal to 3% per annum.
F3 Yekaterina (Katie) Chudnovsky is the sole member and manager of the Purchaser and may be deemed to beneficially own the shares held by the Purchaser.